Updated:
Mountain Pacific Venture Partners
Mountain Pacific Venture Partners invests in early-stage biotech and life sciences companies with established proof-of-concept. The firm has made 9...
Mountain Pacific Venture Partners
Mountain Pacific Venture Partners invests in early-stage biotech and life sciences companies with established proof-of-concept. The firm has made 9 investments, including a Seed VC investment in Alterra Medical on August 31, 2021. Mountain Pacific Venture Partners has 1 portfolio exit, Decoy Biosystems, which exited on March 15, 2021.
General information
Firm type
Venture Capital
Location
Region
North America
Country
United States
City
Salt Lake City
Corporate office
Salt Lake City, UT, United States
Sector focus
Frequently asked questions
Does Mountain Pacific Venture Partners participate in fund commitments or only direct deals?
The firm focuses on direct investments in private companies. Its public profile does not indicate any fund-of-funds or secondary market activity. All known activity involves direct growth-equity positions.
What investment stages does Mountain Pacific Venture Partners typically target?
The firm targets growth-stage investments, focusing on later-stage private companies with proven revenue models. It does not appear to engage in seed or early-stage venture investing.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: